APT 0.00% $66.47 afterpay limited

Smokey, I am not going to get into debates but Gileads Science...

  1. 391 Posts.
    lightbulb Created with Sketch. 73

    Smokey, I am not going to get into debates but Gileads Science must be able to produce Remdesivir failry quickly as they are handing out some doses across 12 countries to approx 1000 patients in each and the trials are for 10 days and 5 days so that means they would be giving between 60K and 120K doses. Now I know that if we are talking a million infected that need treatment, then they will need doses in the millions but I dont know if it will take 12 months for known drugs that they already have a production line for???

    Maybe I am wrong?
 
watchlist Created with Sketch. Add APT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.